ORIC · Oric Pharmaceuticals, Inc. · Documents
$13.91
+1.19 (+9.36%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.32B
Shares
103.65M
Volume · Oct 20
1.98M
Avg daily vol (3M)
1.49M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-15 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| 8-K | — | 2026-08-03 | — | |
| 10-Q | — | 2026-08-03 | 2026-06-30 | |
| 8-K | — | 2026-07-30 | 2026-07-28 | |
| 8-K | — | 2026-06-22 | 2026-06-18 | |
| Investor Event Transcript | — | 2026-06-09 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| 8-K | — | 2026-05-04 | — | |
| 10-Q | — | 2026-05-04 | 2026-03-31 | |
| DEFA14A | — | 2026-04-28 | — | |
| DEF 14A | — | 2026-04-28 | 2026-06-18 | |
| 8-K | — | 2026-03-31 | — | |
| 10-K | — | 2026-02-23 | 2025-12-31 | |
| 8-K | — | 2026-02-23 | — | |
| 8-K | — | 2026-02-23 | — | |
| 8-K | — | 2025-12-08 | 2025-12-06 | |
| 10-Q | — | 2025-11-13 | 2025-09-30 | |
| 8-K | — | 2025-11-13 | — | |
| 8-K | — | 2025-11-13 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-08-12 | — | |
| 8-K | — | 2025-06-13 | 2025-06-11 | |
| S-3 | — | 2025-06-11 | — | |
| 8-K | — | 2025-05-28 | 2025-05-23 | |
| 10-Q | — | 2025-05-05 | 2025-03-31 | |
| 8-K | — | 2025-05-05 | — | |
| DEF 14A | — | 2025-04-23 | 2025-06-11 | |
| DEFA14A | — | 2025-04-23 | — | |
| 8-K | — | 2025-03-14 | 2025-03-11 | |
| 8-K | — | 2025-02-25 | — | |
| 10-K | — | 2025-02-18 | 2024-12-31 | |
| 8-K | — | 2025-02-18 | — | |
| 8-K | — | 2025-01-13 | — | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-11-12 | — | |
| 10-Q | — | 2024-08-12 | 2024-06-30 | |
| 8-K | — | 2024-08-12 | — | |
| 8-K | — | 2024-06-14 | 2024-06-12 | |
| 8-K | — | 2024-05-06 | — | |
| 10-Q | — | 2024-05-06 | 2024-03-31 | |
| DEFA14A | — | 2024-04-24 | — | |
| DEF 14A | — | 2024-04-24 | 2024-06-12 | |
| 8-K | — | 2024-03-29 | 2024-03-26 | |
| 10-K | — | 2024-03-11 | 2023-12-31 | |
| S-3ASR | — | 2024-03-11 | — | |
| 8-K | — | 2024-03-11 | — | |
| S-3 | — | 2024-01-26 | — | |
| 8-K | — | 2024-01-22 | 2024-01-20 | |
| 8-K | — | 2024-01-09 | — |
Showing 1–50 of 115 filings
Key facts
CIK
1796280
CUSIP
68622P109
13F (30d)
11 filings
11 filers
Visit website
Investor relations